231 related articles for article (PubMed ID: 33878140)
21. Intermittent preventive treatment of pregnant women in Kintampo area of Ghana with sulphadoxine-pyrimethamine (SP): trends spanning 2011 and 2015.
Oppong FB; Gyaase S; Zandoh C; Nettey OEA; Amenga-Etego S; Anane EA; Adda R; Dosoo DK; Owusu-Agyei S; Asante KP
BMJ Open; 2019 Jun; 9(6):e027946. PubMed ID: 31230017
[TBL] [Abstract][Full Text] [Related]
22. Factors influencing adherence to the new intermittent preventive treatment of malaria in pregnancy policy in Keta District of the Volta region, Ghana.
Vandy AO; Peprah NY; Jerela JY; Titiati P; Manu A; Akamah J; Maya ET; Torpey K
BMC Pregnancy Childbirth; 2019 Nov; 19(1):424. PubMed ID: 31747927
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women attending antenatal clinic in Bobo-Dioulasso (Burkina Faso).
Cisse M; Sangare I; Lougue G; Bamba S; Bayane D; Guiguemde RT
BMC Infect Dis; 2014 Nov; 14():631. PubMed ID: 25408152
[TBL] [Abstract][Full Text] [Related]
24. Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes.
Valea I; Tinto H; Drabo MK; Huybregts L; Henry MC; Roberfroid D; Guiguemde RT; Kolsteren P; D'Alessandro U;
Malar J; 2010 Nov; 9():324. PubMed ID: 24576068
[TBL] [Abstract][Full Text] [Related]
25. Late ANC initiation and factors associated with sub-optimal uptake of sulphadoxine-pyrimethamine in pregnancy: a preliminary study in Cape Coast Metropolis, Ghana.
Amoako BK; Anto F
BMC Pregnancy Childbirth; 2021 Feb; 21(1):105. PubMed ID: 33530957
[TBL] [Abstract][Full Text] [Related]
26. A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana.
Clerk CA; Bruce J; Affipunguh PK; Mensah N; Hodgson A; Greenwood B; Chandramohan D
J Infect Dis; 2008 Oct; 198(8):1202-11. PubMed ID: 18752443
[TBL] [Abstract][Full Text] [Related]
27. Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon.
Anchang-Kimbi JK; Kalaji LN; Mbacham HF; Wepnje GB; Apinjoh TO; Ngole Sumbele IU; Dionne-Odom J; Tita ATN; Achidi EA
Malar J; 2020 Mar; 19(1):100. PubMed ID: 32122339
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and risk factors of malaria and anaemia and the impact of preventive methods among pregnant women: A case study at the Akatsi South District in Ghana.
Ahadzie-Soglie A; Addai-Mensah O; Abaka-Yawson A; Setroame AM; Kwadzokpui PK
PLoS One; 2022; 17(7):e0271211. PubMed ID: 35877761
[TBL] [Abstract][Full Text] [Related]
29. An ethnographic study of how health system, socio-cultural and individual factors influence uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a Ghanaian context.
Aberese-Ako M; Magnussen P; Ampofo GD; Gyapong M; Ansah E; Tagbor H
PLoS One; 2021; 16(10):e0257666. PubMed ID: 34618812
[TBL] [Abstract][Full Text] [Related]
30. Uptake of intermittent preventive treatment of malaria in pregnancy and risk factors for maternal anaemia and low birthweight among HIV-negative mothers in Dschang, West region of Cameroon: a cross sectional study.
Kamga SLS; Ali IM; Ngangnang GR; Ulucesme MC; Keptcheu LTD; Keming EM; Tchuenkam VK; Foyet JV; Aktas M; Noubom M; Payne VK
Malar J; 2024 Jan; 23(1):6. PubMed ID: 38178125
[TBL] [Abstract][Full Text] [Related]
31. Characterization of asymptomatic Plasmodium falciparum infection and its risk factors in pregnant women from the Republic of Congo.
Francine N; Damien B; Anna F; Michael K; Christevy VJ; Felix KK
Acta Trop; 2016 Jan; 153():111-5. PubMed ID: 26477849
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania.
Mosha D; Chilongola J; Ndeserua R; Mwingira F; Genton B
Trop Med Int Health; 2014 Sep; 19(9):1048-56. PubMed ID: 24965022
[TBL] [Abstract][Full Text] [Related]
33. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016.
Azizi SC
BMC Public Health; 2020 Mar; 20(1):335. PubMed ID: 32178658
[TBL] [Abstract][Full Text] [Related]
34. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.
Azizi SC; Chongwe G; Chipukuma H; Jacobs C; Zgambo J; Michelo C
BMC Pregnancy Childbirth; 2018 Apr; 18(1):108. PubMed ID: 29678150
[TBL] [Abstract][Full Text] [Related]
35. Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women.
Wilson NO; Ceesay FK; Obed SA; Adjei AA; Gyasi RK; Rodney P; Ndjakani Y; Anderson WA; Lucchi NW; Stiles JK
Am J Trop Med Hyg; 2011 Jul; 85(1):12-21. PubMed ID: 21734118
[TBL] [Abstract][Full Text] [Related]
36. Factors affecting uptake of ≥ 3 doses of Sulfadoxine-Pyrimethamine for malaria prevention in pregnancy in selected health facilities, Arusha region, Tanzania.
Mchwampaka WM; Tarimo D; Chacky F; Mohamed A; Kishimba R; Samwel A
BMC Pregnancy Childbirth; 2019 Nov; 19(1):440. PubMed ID: 31775686
[TBL] [Abstract][Full Text] [Related]
37. Intermittent use of sulphadoxine-pyrimethamine for malaria prevention: a cross-sectional study of knowledge and practices among Ugandan women attending an urban antenatal clinic.
Odongo CO; Bisaso RK; Byamugisha J; Obua C
Malar J; 2014 Oct; 13():399. PubMed ID: 25306431
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi.
Gutman J; Mwandama D; Wiegand RE; Ali D; Mathanga DP; Skarbinski J
J Infect Dis; 2013 Sep; 208(6):907-16. PubMed ID: 23801600
[TBL] [Abstract][Full Text] [Related]
39. Sulfadoxine-pyrimethamine parasitological efficacy against Plasmodium falciparum among pregnant women and molecular markers of resistance in Zambia: an observational cohort study.
Chaponda EB; Mharakurwa S; Michelo C; Bruce J; Chandramoha D; Matthew Chico R
Malar J; 2021 Jan; 20(1):61. PubMed ID: 33482823
[TBL] [Abstract][Full Text] [Related]
40. The Effectiveness of the Revised Intermittent Preventive Treatment with Sulphadoxine Pyrimethamine (IPTp-SP) in the Prevention of Malaria among Pregnant Women in Northern Ghana.
Agyeman YN; Newton SK; Annor RB; Owusu-Dabo E
J Trop Med; 2020; 2020():2325304. PubMed ID: 33299426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
